HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alessandra Cupri Selected Research
Alessandra Cupri Research Topics
Disease
5
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 06/2015
5
Multiple Myeloma
01/2020 - 01/2008
4
Infections
09/2023 - 12/2017
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2023 - 11/2020
3
Neoplasms (Cancer)
12/2022 - 01/2008
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2017 - 05/2010
2
Hematologic Diseases (Blood Diseases)
09/2023 - 01/2023
2
Nausea
02/2022 - 11/2020
2
Vomiting
02/2022 - 11/2020
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2008
2
Leukemia
01/2022 - 02/2013
2
Hematologic Neoplasms (Hematological Malignancy)
02/2013 - 08/2012
1
Breakthrough Infections
09/2023
1
COVID-19
09/2023
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2023
1
Primary Myelofibrosis (Myelosclerosis)
01/2023
1
Leishmaniasis
01/2023
1
Renal Insufficiency (Renal Failure)
12/2022
1
Hypothyroidism
12/2022
1
Myositis (Idiopathic Inflammatory Myopathies)
12/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Capillary Leak Syndrome
01/2022
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022
1
Thrombotic Microangiopathies
01/2022
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1
Lymphoma (Lymphomas)
01/2014
1
Genetic Translocation (Chromosomal Translocation)
05/2010
Drug/Important Bio-Agent (IBA)
3
plerixafor
FDA Link
01/2020 - 01/2014
3
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2020 - 01/2014
2
Monoclonal Antibodies
IBA
09/2023 - 12/2022
2
Cytokines
IBA
01/2023 - 01/2019
2
netupitant
IBA
02/2022 - 11/2020
2
Palonosetron (Aloxi)
FDA Link
02/2022 - 11/2020
2
Dexamethasone (Maxidex)
FDA Link
Generic
11/2020 - 01/2014
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2020 - 01/2014
2
Imatinib Mesylate (Gleevec)
FDA Link
12/2017 - 02/2013
2
Tyrosine Kinase Inhibitors
IBA
12/2017 - 05/2010
1
tixagevimab
IBA
09/2023
1
cilgavimab
IBA
09/2023
1
Antibodies
IBA
01/2023
1
ruxolitinib
IBA
01/2023
1
Immune Checkpoint Inhibitors
IBA
12/2022
1
fludarabine
IBA
01/2022
1
Busulfan (Busulfex)
FDA Link
01/2022
1
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
01/2022
1
Neurokinin-1 Receptor Antagonists
IBA
11/2020
1
Antiemetics
IBA
11/2020
1
Serotonin (5 Hydroxytryptamine)
IBA
11/2020
1
Proteasome Inhibitors
IBA
01/2019
1
Immunomodulating Agents
IBA
01/2019
1
ponatinib
IBA
01/2018
1
Methylprednisolone
FDA Link
Generic
12/2017
1
Steroids
IBA
12/2017
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2014
1
Cisplatin (Platino)
FDA Link
Generic
01/2014
1
Proteins (Proteins, Gene)
FDA Link
02/2013
1
Infliximab (Remicade)
FDA Link
08/2012
1
Bortezomib (Velcade)
FDA Link
01/2008
Therapy/Procedure
4
Drug Therapy (Chemotherapy)
12/2022 - 01/2018
4
Hematopoietic Stem Cell Transplantation
01/2022 - 01/2018
3
Therapeutics
09/2023 - 08/2012
2
Transplantation
12/2022 - 01/2021
2
Stem Cell Transplantation
02/2022 - 11/2020
1
Immunotherapy
12/2022
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2018
1
Homologous Transplantation
06/2015
1
Aftercare (After-Treatment)
02/2013